checkAd

     320  0 Kommentare Novavax to Host Conference Call to Discuss Third Quarter 2014 Financial Results on November 5, 2014

    GAITHERSBURG, Md., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that it will report its financial results for the third quarter of 2014 on Wednesday, November 5, 2014, after market close.

    In addition, management will host a conference call, to discuss the quarterly financial results and provide an update on corporate activities.

    Conference call details are as follows:

    Date:  November 5, 2014
    Time: 4:30 PM US eastern time
    Dial-in number: 1 (877) 212-6076 (domestic) or 1 (707) 287-9331 (international)
    Via Web:  www.novavax.com

    Conference call replay:

    Dates: Starting at 6:31pm on November 5, 2014 until midnight November 12, 2014
    Dial-in number: 1 (855) 859-2056 (domestic) or 1 (404) 537-3406 (international)
    Passcode: 27652087
    Via-Web: www.novavax.com, "Investor Info"/"Events"

    About Novavax

    Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant protein nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. Additional information about Novavax is available on the company's website, novavax.com.

    CONTACT: Barclay Phillips
             SVP, Chief Financial Officer and Treasurer
             Novavax, Inc.
             240-268-2000




    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Novavax, Inc. via Globenewswire

    HUG#1867028


    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    Novavax to Host Conference Call to Discuss Third Quarter 2014 Financial Results on November 5, 2014 Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that it will report its financial results for the …

    Schreibe Deinen Kommentar

    Disclaimer